Literature DB >> 12801775

Clinical efficacy and toxicity of gefitinib in patients with lung cancer.

Shinji Teramoto, Hiroshi Yamamoto, Yasuyoshi Ouchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12801775     DOI： 10.1016/S0140-6736(03)13573-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  A case of methylprednisolone treatment for interstitial pneumonia induced by gefitinibin.

Authors:  Jun Yan; Chun Wang; Qinfang Zhang; Xiaoou Chen; Weiwei Yu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities.

Authors:  Sabari Vallath; Robert E Hynds; Laura Succony; Sam M Janes; Adam Giangreco
Journal:  Eur Respir J       Date:  2014-01-16       Impact factor: 16.671

3.  Progressive multiple cystic changes in both lungs in a patient treated with gefitinib for lung adenocarcinoma with multiple lung metastases.

Authors:  Yon Ju Ryu; Eun Mi Chun; Soon Nam Lee; Sung Shin Shim
Journal:  Korean J Radiol       Date:  2014-03-07       Impact factor: 3.500

4.  Gefitinib-induced interstitial pneumonia: A case report and review of the literature.

Authors:  Changqin Luo; Meiling Lv; Yuyao Li; Peijun Liu; Jin Yang
Journal:  Exp Ther Med       Date:  2014-01-21       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.